{
  "bio": [
    "David Dean Halbert became a billionaire in June 2025 when the diagnostics firm he built up, Caris Life Sciences, went public on the Nasdaq.",
    "In 2008 Halbert acquired a small biotech firm called Molecular Profiling Institute, then greatly expanded it and renamed it Caris Life Sciences; he owns a 44% stake.",
    "Caris Life Sciences uses gene sequencing, AI and machine learning for early disease detection; revenue at the unprofitable company grew to $412 million in 2024.",
    "Halbert previously founded pharmacy benefit manager AdvancePCS in 1987. He took it public and later sold it to Caremark for $7.5 billion in 2004",
    "He has been an active buyer and seller of healthcare businesses through his Caris Capital."
  ],
  "about": []
}